Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Role in Therapy and Strategies to Overcome Resistance

Author： Depta Jeremiah P.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.2, 2008-01, pp. : 91-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

By Hillegass W.B.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 41-55

Adis International

Access to resources Recommend Favorite

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Revascularisation: A Review of Trial Reports

By Kong D.F.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 609-620

Adis International

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A   Mazzola Jennifer L   Przylenk Karin  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite